CCND1 and Lynch syndrome: The aim of the study was to evaluate the expression of p53, cyclin D1, β-catenin, APC and c-myc proteins in patients with colorectal cancer or gastric cancer with suspected of Lynch syndrome by Bethesda criteria and loss of expression of MLH1, MSH2, MSH6 and PMS2